Non-Commercial Use Only

Total Page:16

File Type:pdf, Size:1020Kb

Non-Commercial Use Only Geriatric Care 2020; volume 6:8703 General practitioner attitudes medications, however almost half expressed and confidence to deprescribing doubts regarding deprescribing when Correspondence: Pier Riccardo Rossi, Scuola medication was initially prescribed by a Piemontese di Medicina Generale; Società for elderly patients colleague (45%) or when patient and/or Italiana di Medicina Generale e delle Cure caregiver supported the opportunity to Primarie; General Practitioner, Torino Local Health Authority, via Emilio Ghione 40, Pier Riccardo Rossi,1-3 Sarah E. Hegarty,4 continue the assumption (49%). Around a 5 6 10156 Torino, Italy. Vittorio Maio, Marco Lombardi, third of doctors maintain that the absence of E-mail: [email protected] Andrea Pizzini,1-3 Aldo Mozzone,1-3 strong evidence supporting deprescribing Marzio Uberti,1-3 Simonetta Miozzo1,2,7 prevents them from considering it (38%), Key words: Deprescribing; general practi- that they do not have the necessary time to tioner; attitude; primary care; elderly. 1Scuola Piemontese di Medicina 2 effectively go through the process of Generale, Torino, Italy; Società Italiana deprescribing (29%), and that fear of Acknowledgments: we thank for their contri- di Medicina Generale e delle Cure possible effects due on withdrawal prevents bution the following tutors of the Scuola Primarie, Torino, Italy; 3General Piemontese di Medicina Generale: Caposieno them from deprescribing (31%). There was M, Araldi M, Boella G, Fassone R, Piano P, Practitioner, Torino Local Health no strong correlation between physicians’ 4 Torta F, Morato P, Di Gravina G, Rumore A, Authority, Torino, Italy; Division of confidence and attitudes or barriers Vitali S, Mandas R, Bianchi S, Raiteri G. Biostatistics, Department of associated with deprescribing. Pharmacology and Experimental The present study confirms that general Contributions: the authors contributed equally. Therapeutics, Thomas Jefferson practitioners sense the importance of deprescribing and feel prepared to face it Conflict of interest: the authors declare no University, Philadelphia, PA, USA; potential conflict of interest. 5College of Population Health, Thomas managing communication with patients and Jefferson University, Philadelphia, PA, caregivers, but find barriers when enacting Received for publication: 2 December 2019. USA; 6Parma Local Health Authority, the practice in a real-life context. Revision received: 19 January 2020. Parma, Italy; 7General Practitioner, Accepted for publication: 24 Janauary 2020. Pinerolo-Collegno Local Health onlyThis work is licensed under a Creative Authority, Pinerolo-Collegno (TO), Italy How this fits in Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Data about physicians’ confidenceuse and ©Copyright: the Author(s), 2020 attitudes toward deprescribing are limited. Licensee PAGEPress, Italy Abstract This study found that general practitioners Geriatric Care 2020; 6:8703 recognize the importance of deprescribing doi:10.4081/gc.2020.8703 Deprescribing is a patient-centered and feel comfortable to undertake the process of medication withdrawal intended deprescribing process with patients and to achieve improved health outcomes caregivers. However, several barriers when through discontinuation of one or more enacting the practice in a real-life context detrimental pharmacological interactions, medications that are either potentially were identified. Study results can be used to falls, decreased cognitive function,2,3 and the harmful or no longer required. plan educational and training activities for decrease in potential pharmacological The objective of this study was to assess primary care physicians and other health benefits. the perceptions of primary care physicians care professionals involved in the Guidelines motivating drug prescription on deprescribing and potential barriers to medication prescription process, as well as derive from case studies on single deprescribing in the Local Health Authority to design strategies for improving patients’ pathologies and in most cases on selected (LHA) of Turin, Piedmont, Italy. Secondary understanding of appropriate use of populations: this approach immediately objective was to evaluate educational needs medications. In addition, these results can excludes polymorbid and/or elderly of primary care physician. provide useful elements for political patients.4-6 It can therefore be said that Cross sectional survey of primaryNon-commercial care decision-makers and for those who are polypharmacy on elderly patients often physicians working in the LHA of Turin, delegated to organize healthcare services for represent isolated experiments.7 The Piedmont, Italy. the elderly. challenge is to establish, based on each 439 GPs (71.3% of the total number of individual patient, whether it is possible to primary care physicians) attended an introduce a new medication or to deprescribe educational session related to deprescribing one based on the current health situation and were asked to anonymously answer a Introduction while also respecting the patient’s and paper survey. Participants were asked to caregiver’s preferences. complete a previously published questionnaire Polypharmacy is an ever-growing Polypharmacy must, therefore, be about deprescribing and potential factors healthcare issue, mainly common in elderly monitored and constantly adapted to the affecting the deprescribing process. patients. While it can sometimes be patient’s needs over time. All healthcare A correlation coefficient was calculated necessary and motivated by multimorbidity,1 practitioners should consider the positive to assess the association between physicians’ polypharmacy can still represent an issue for and negative potential of polypharmacy, but confidence in deprescribing and attitudes or at least two main reasons: the risk of the best-suited figures to take care of the barriers associated with deprescribing. pharmacological interactions and adverse problem are General Practitioners (GPs) who Many GPs (71%) reported general reactions (ADR) on the one hand and a operate in the context of primary care and confidence in their ability to deprescribe. decrease in compliance (adherence to the are ultimately in charge of caring for the Most respondents (83%) reported they were therapy) on the other hand. Consequences person and have knowledge of their history comfortable deprescribing preventive can be excessive hospitalization because of and quality of life. [Geriatric Care 2020; 6:8703] [page 1] Article Deprescribing has recently been defined such as suspension of a drug for either deprescribing, however almost half as follows: a patient-centered process of preventive or therapeutic use, the ability to expressed doubts regarding deprescribing medication withdrawal intended to achieve motivate patients towards deprescribing, and when medication was initially prescribed by improved health outcomes through the barriers to deprescribing. Doctors were a colleague (45%) or when patient and/or discontinuation of one or more medications asked to indicate the degree to which they caregiver supported the opportunity to that are either potentially harmful or no agreed with the nine statements using a continued use of said drugs (49%). Around longer required.8 Such a process can very Likert-type scale ranging from 1 (highly a third of doctors maintain that the absence well be referred to the concept of Quaternary disagree) to 7 (strongly agree). of strong evidence supporting deprescribing Prevention (P4).9 P4 is defined as: Actions During the year 2018 a group of tutors prevents them from considering it (38%), taken to identify a patient or a population at instructed by the Scuola Piemontese di that they do not have the necessary time to risk of over-medicalization, to protect Medicina Generale (School of General effectively go through the process of him/her from invasive medical procedures, medicine in Piedmont) developed and deprescribing (29%), and the fear of possible and to offer them ethically and medically presented an educational program on effects brought on from the interruption of acceptable treatment procedures.10 P4 is a deprescribing sponsored by the Turin LHA. said drugs could possibly prevent them from critical look at medical activities with an The seminars, held over the course of two deprescribing (31%). (Table 3). emphasis on the need not to harm.11 and is evenings, were mandatory and took place Correlation analyses between the first consider by WONCA a task for GPs.9 Some within the context of monthly team meetings statement and other statements revealed a studies evaluated the effectiveness of from April 2018 to November 2018. The weak correlation between perceived level of deprescribing, finding improved quality of questionnaire was voluntary and anonymous expertise and the ability to deprescribe life and no association to significant risks or and was presented at the beginning of the medication initially prescribed by another withdrawal symptoms.12,13 Of the potential second evening (October-November 2018). colleague (fifth statement, rho=0.33) and the benefits, there are still many obstacles that All answers were collected on paper and ability to motivate the patient to begin the make deprescribing difficult for physicians. then keyed into an excel spreadsheet. process of deprescribing ( ninth statement, Some studies highlight how the lack of time, Descriptive statistics were calculated to rho= 0.33) (Table 4.) Overall, there was no difficulty communicating
Recommended publications
  • Polypharmacy and the Senior Citizen: the Influence of Direct-To-Consumer Advertising
    2021;69:19-25 CLINICAL GETRIATRICS - ORIGINAL INVESTIGATION doi: 10.36150/2499-6564-447 Polypharmacy and the senior citizen: the influence of direct-to-consumer advertising Linda Sperling, DHA, MSN, RN1, Martine B. Fairbanks, Ed.D, MA, BS2 1 College of nursing, University of Phoenix, Arizona, USA; 2 College of doctoral studies, University of Phoenix, Arizona, USA Background. Polypharmacy, or taking five or more medications dai- ly, can lead to poor medication compliance and an increased risk for adverse drug-to-drug interactions that may eventually lead to death. The study was designed to explore the questions of how age, the re- lationship between the physician and patient, and television, radio, magazines and modern electronic technology, such as the Internet, affect patients’ understanding of their medical care. Two main areas addressed in this research study included the pharmaceutical indus- try’s influence on consumer decisions to ask a physician for a particular medication, and the prescribing practices of the physician. Methods. This qualitative phenomenological study began with pre- screening volunteer residents in a nursing home to discover poten- tial participants who met the criteria of using five or more medicines daily. We then interviewed 24 participants who met the criteria, using semi-structured interview questions. Results. Four core themes emerged from this study: professional trust, professional knowledge, communication deficit, and direct-to-consum- Received: April 30, 2020 er advertising. Participants reported trusting their doctors and taking Accepted: November 2, 2020 medications without question, but most knew why they were taking the Correspondence medications. Participants also reported seeing ads for medications, but Linda Sperling DHA, MSN, RN only one reported asking a physician to prescribe the medication.
    [Show full text]
  • 2019 Abstract Book
    2019 NATIONAL MEETING / ÉDITION 2019 DU CONGRÈS ANNUEL: TAKING ACTION LE SURDIAGNOSTIC : PASSEZ À L’ACTION ABSTRACT BOOK CAHIER DES RÉSUMÉS Dear National Meeting Attendees, We are excited to be hosting the National Meeting in Montreal, Quebec and for the first time featuring both English and French sessions. I would like to thank our co-host, the Quebec Medical Association and our partner, the Canadian Medical Association for their contributions to this year’s event. The 2019 National Meeting includes a special celebration marking the fifth anniversary of the Choosing Wisely Canada campaign. I am thrilled to celebrate this important milestone with the Choosing Wisely Canada community and recognize our collective efforts in reducing unnecessary tests and treatments. In the past five years, Choosing Wisely Canada has evolved from a conversation between clinicians and patients to the national voice for reducing unnecessary tests and treatments in health care. There has been unparalleled engagement and dedication from clinicians, administrators, researchers and systems leaders. There are close to 350 quality improvement projects related to the campaign taking root across the country and 12 active provincial and territorial campaigns to help accelerate the pace of change locally. As Chair of Choosing Wisely Canada, I am proud of the sizable impact our community has had in Canada and the momentum the campaign has gained. This year’s theme Taking Action is reflective of our next chapter of the campaign. The abstracts featured in this book are a testament to the breadth of projects taking place from coast-to-coast and showcase the energy of our community in putting campaign recommendations into practice.
    [Show full text]
  • Deprescribing
    A GUIDE TO deprescribing OPIOIDS KEY POINTS CONTEXT This guide considers the use of opioid medications U Opioid therapy is not indicated for the long- in the treatment of chronic non-cancer pain. term management of chronic non-cancer pain. U Opioid treatment of chronic non-cancer RECOMMENDED pain does not seem to fulfil any of the key DEPRESCRIBING STRATEGY opioid treatment goals: pain relief, improved quality of life and improved functional Deprescribing or tapering of opioids is more likely to be successful when the person is aware of the issues with capacity. long term opioid use. U Opioids are playing a diminishing role in the A number of consumer resources are available to assist modern management of chronic pain. with management of chronic pain. A good quality Australian resource is available through the Hunter U Multidisciplinary pain management Integrated Pain Service at www.hnehealth.nsw.gov.au/ programs utilising psychology, exercise and pain/. functional-based outcomes result in better There are multiple sections written for consumers on quality of life and better pain management understanding chronic pain, and understanding five key than use of opioids. treatment areas: Biomedical, Mindbody, Connection, Activity and Nutrition. U Tolerance to the analgesic effects of opioids People with chronic non-cancer pain taking long term develops in almost all people with long term oral morphine milligram equivalent of: use. U 120mg or more daily should be considered for opioid deprescribing. This will usually include dose reduction U Long term opioid use is associated with with or without opioid rotation accompanied by serious adverse hormonal and psychological appropriate education and information.
    [Show full text]
  • Donzelot, Anti-Sociology
    An Anti- sociology JACQUES DONZELOT What was it that brought a man, one day, to stretch out on the analyst's couch to relate the details of his life? This is in a sense the question Michel Foucault raised in Madness and Civilization. In order to solve this problem, Foucault described an historical sequence of three centuries during which time the division separating madness and normality was plotted. The results of his investigation show psychoanalysis to be situated at the outermost point of the confinement trappings without foregoing its fundamental implications: "Freud did deliver the patient from the existence of the asylum within which his 'liberators' had alienated him; but he did not deliver him from what was essential in this existence ... he created the psychoanalytical situation in which, by an inspired short-circuit, alienation becomes disalienation, but the doctor as alienating figure remains the key to psychoanalysis." Yes, one could tell his life history on the couch. But in such conditions as this, Foucault wonders, what was to be understood? Foucault's impertinent conclusion directed at psychoanalysis was to please Gilles Deleuze and Felix Guattari to such an extent that they used it as a starting point for their own book and were able to systematically demolish psychoanalysis, construct a new theory of desire and, while they were at it, sketch the evolution of mankind from its origins to the present day. Each of these three aspects has been spoken about differently. The first aspect has been overly discussed, owing, it would D&G systematically seem, to the book's satirical demolish psychoanalysis, style aimed at ridiculing construct a new theory of psychoanalysis.
    [Show full text]
  • Medicalisation and Overdiagnosis: What Society Does to Medicine Wieteke Van Dijk*, Marjan J
    http://ijhpm.com Int J Health Policy Manag 2016, 5(11), 619–622 doi 10.15171/ijhpm.2016.121 Perspective Medicalisation and Overdiagnosis: What Society Does to Medicine Wieteke van Dijk*, Marjan J. Faber, Marit A.C. Tanke, Patrick P.T. Jeurissen, Gert P. Westert Abstract The concept of overdiagnosis is a dominant topic in medical literature and discussions. In research that Article History: targets overdiagnosis, medicalisation is often presented as the societal and individual burden of unnecessary Received: 2 May 2016 medical expansion. In this way, the focus lies on the influence of medicine on society, neglecting the possible Accepted: 23 August 2016 influence of society on medicine. In this perspective, we aim to provide a novel insight into the influence of ePublished: 31 August 2016 society and the societal context on medicine, in particularly with regard to medicalisation and overdiagnosis. Keywords: Medicalisation, Overdiagnosis, Society Copyright: © 2016 The Author(s); Published by Kerman University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http:// creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. *Correspondence to: Citation: van Dijk W, Faber MJ, Tanke MA, Jeurissen PP, Westert GP. Medicalisation and overdiagnosis: Wieteke van Dijk what society does to medicine. Int J Health Policy Manag. 2016;5(11):619–622. doi:10.15171/ijhpm.2016.121
    [Show full text]
  • The Problem of Power in ADHD: a Scoping Review
    The Problem of Power in ADHD: A Scoping Review Abraham Joseph Student number 211190287 Supervisor’s Name: Marina Morrow Advisor’s Name: Mary Wiktorowicz Supervisor’s Signature: Date Approved: June 10, 2020 Advisor’s Signature: Date Approved: June 10, 2020 A Research Paper submitted to the Graduate Program in Health in partial fulfillment of the requirements for the degree of: Master of Arts Graduate Program in Health York University Toronto, Ontario M3J 1P3 Defend date: June 10, 2020 1 Table of Contents Table of Contents 2 Abstract 4 Introduction 5 Background 6 Research Goals 12 Theoretical Frameworks/Methodology 14 Research Paradigm 14 Scoping Review Method 17 Search Strategy 18 Inclusion and Exclusion Criteria 20 Data Extraction and Analysis 20 Findings and Discussion 21 Nature of Evidence 21 Places of Psychiatric Power 23 Patterns of Psychiatric Power 26 Problems of Psychiatric Power 38 Strengths and Limitations 55 Implications and Conclusions 57 2 Acknowledgements 59 References 60 Appendix A – Database Search Flow Chart 71 Appendix B – Scoping Review Charting Summary 72 3 Abstract Attention deficit hyperactivity disorder (ADHD) has become the most diagnosed mental health issue for children worldwide. There are substantive critiques of the psychiatric basis for the conceptualization, diagnosis, and treatment that dominate the ADHD context. ADHD discourse and practice are largely influenced by the biomedical framework of mental health and illness. The pervasive, continued acceptance of the dominant biomedical ADHD narrative is problematic in terms of addressing mental health care needs as well as illustrative of the influence and power that psychiatry wields with respect to the ADHD landscape.
    [Show full text]
  • The Frail Elderly and Integral Health Management Centered on the Individual and the Family Editorial 307
    http://dx.doi.org/10.1590/1981-22562017020.170061 The frail elderly and integral health management centered on the individual and the family Editorial 307 The rapid aging of the Brazilian population, combined with an increase in longevity, has had serious consequences for the structure of health care networks, with an increased burden of chronic diseases and especially of functional disabilities. Unfortunately, the care offered to frail elderly people with multiple chronic health conditions, poly-disabilities or complex needs is fragmented, inefficient, ineffective and discontinuous, which can further harm their health. The hospital-based health system of the 19th and 20th centuries that is designed to deal with acute and especially infectious diseases is inadequate for meeting the needs of chronic patients for long-term, continuous treatment. The response of the health system to the new demands means the use of a set of management technologies that are capable of ensuring optimal standards of health care in a resolutive, efficient, scientifically structured manner, which is safe for patients and health professionals, timely, equitable, humanized and sustainable, is essential. The threefold goal of a better care experience, coupled with improved populational health and reduced costs developed by the Institute of Healthcare Improvement (Triple Aim), is the best strategy for reorganizing and optimizing health system performance. Providing the best care experience means understanding the particularities of health in the elderly. The use of parameters based on risk factors, diseases and/or age is inappropriate and is associated with a high risk of iatrogenic illness. Vitality is extremely heterogeneous among the elderly and chronological age is a precarious metric for the assessment of the homeostatic reserve of the individual.
    [Show full text]
  • Results of the Self-Assessment of Essential Public Health Operations Foreword
    The WHO Regional The World Health Organization (WHO) is a specialized agency of the United Nations created in 1948 with the primary responsibility for international health matters each with its own programme geared to the particular health conditions of the countries it serves. Member States Albania Andorra Ministry of Health of the Kyrgyz Republic Armenia Austria Azerbaijan Belarus Belgium Results of the self-assessment of Bosnia and Herzegovina Bulgaria Croatia essential public health operations Cyprus Czechia in the Kyrgyz Republic Denmark Estonia Finland April–September 2016 France Georgia Germany Greece Bishkek 2017 Hungary Iceland Ireland Israel Italy Kazakhstan Kyrgyzstan Latvia Lithuania Luxembourg Malta Monaco Montenegro Netherlands Norway Poland Portugal Republic of Moldova Romania Russian Federation San Marino Serbia Slovakia Slovenia Spain Sweden Switzerland Tajikistan The former Yugoslav Republic of Macedonia Turkey Turkmenistan Ukraine United Kingdom UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark Uzbekistan Tel.: +45 45 33 70 00 Fax: +45 45 33 70 01 E-mail: [email protected] ABSTRACT This report presents the results of Kyrgyzstan’s self-assessment of the essential public health operations (EPHOs). The EPHO self-assessment was initiated by the Ministry of Health of the Kyrgyz Republic and conducted under the biennial collaborative agreement between the WHO Regional Office for Europe and the Government of Kyrgyzstan for 2016–2017. In addition to describing the assessment process, the technical report presents the key recommendations put forth by the Steering Committee and Specialized Teams. KEYWORDS ESSENTIAL PUBLIC HEALTH OPERATIONS HEALTH POLICY HEALTH SYSTEM PLANS – ORGANIZATION AND ADMINISTRATION HEALTH SYSTEM REFORM HEALTH SYSTEMS ASSESSMENT HEALTH SYSTEM STRENGTHENING PUBLIC HEALTH STRATEGY Address requests about publications of the WHO © World Health Organization 2017 All rights reserved.
    [Show full text]
  • Quaternary Prevention: a Balanced Approach to Demedicalisation
    Life & Times Quaternary prevention: a balanced approach to demedicalisation In 1982, the Journal of the Royal College of General Practitioners published Ivan Illich’s “The main problem of overdiagnosis is overtreatment: article ‘Medicalization in Primary Care’.1 Illich held a paradoxical belief that GPs treating pseudo-diseases that bear no prospect of could contribute to the healthy process of benefit.” demedicalisation, that is: ‘... to offer their patients the occasion to patients end up dying from competing 10 years.7 This increases the overdiagnosis de-medicalize their own attitude to pain, diseases and not gaining in longevity. effect and offers minimal individual benefit. disability, discomfort, ageing, birth and The main problem of overdiagnosis is Regarding P2, there are lots of instances 1 death.’ overtreatment: treating pseudo-diseases of overmedicalisation due to non-evidence- that bear no prospect of benefit.6 This based screening for thyroid, prostate, and In other words, ‘unhooking [patients] represents harm both to individuals’ ovarian cancers. Breast cancer screening 1 from the health system’. This article wellbeing and to health systems as also needs to be readdressed. After an presents WONCA’s definition of Quaternary it generates unnecessary costs and average of two decades of breast cancer Prevention (P4) as a unifying framework that waste of resources. Potential sources screening in Canada8 and the US,9 there 2 organises GPs’ scope on demedicalisation. of overdiagnosis are disease screening, are considerable overdiagnosis rates altering cut-off points for defining a risk (roughly 30%), minimal (if any) impacts on EXPLAINING QUATERNARY PREVENTION factor or a disease, and financial incentives mortality,10 but known potential harms such Devised in 1986 by Marc Jamoulle, a (for example, pay-for-performance as an increase in heart disease (27%) and Belgian GP, P4 is: schemes).5 lung cancer (78%) mortality.11 Concerning P3, diabetes care provides a ‘..
    [Show full text]
  • Mental Health in Ukraine
    2021 Yale Institute for Global Health Case Competition Mental Health in Ukraine 2021 Yale Institute for Global Health Case Competition Case Writing Team: Sina Reinhard (Chair), Yale School of Public Health Annan Dang, Yale School of Public Health Mitchelle Matesva, Yale School of Medicine Patricia Ryan-Krause, Yale School of Nursing (Faculty Advisor) Special thanks to Marie Brault for review of the case The scenarios, prompt, and vignettes of this case are based on existing initiatives, organizations, and individuals; however, details have been dramatized. Materials beyond the case scenario and prompt are meant to portray an accurate representation of global mental health and Ukraine’s burden of mental illness. The authors have provided facts and figures within the case and appendices to help teams. The data provided are derived from independent sources, may have been adapted for use in this case, and are clearly cited such that teams can verify or contest the findings within their recommendations if it is pertinent to do so. Introduction In January 2020, Ukraine was selected as a priority country for the World Health Organization’s (WHO) Special Initiative for Mental Health (2019-2023). Ukraine carries a high burden of mental illness with a particularly high prevalence of depression in comparison to other countries. Mental disorders are the country’s second leading cause of disability burden in terms of disability adjusted life years and are estimated to affect 30% of the population [100]. Since joining the initiative, Ukraine has experienced a renewed political commitment to mental health policy and service expansion combined with growing public interest in mental health issues.
    [Show full text]
  • Self-Assessment Tool for the Evaluation of Essential Public Health
    The WHO Regional Office for Europe SELF-ASSESSMENT TOOL FOR THE EVALUATION OF ESSENTIAL PUBLIC HEALTH OPERATIONS IN THE WHO EUROPEAN REGION The World Health Organization (WHO) is a specialized agency of the United Nations created in 1948 with the primary responsibility for international health matters and public health. The WHO Regional Office for Europe is one of six regional offices throughout the world, each with its own programme geared to the particular health conditions of the countries it serves. Member States Albania Andorra Armenia Austria Azerbaijan Belarus Belgium Bosnia and Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Georgia Germany Greece Hungary Iceland Ireland Israel Italy Kazakhstan Kyrgyzstan Latvia Lithuania Luxembourg Malta Monaco Montenegro Netherlands Norway Self-assessment tool for the Poland Portugal evaluation Republic of Moldova Romania Russian Federation of essential public health San Marino Serbia operations Slovakia Slovenia in the WHO European Region Spain Sweden Switzerland Tajikistan The former Yugoslav Republic of Macedonia Turkey Turkmenistan Ukraine United Kingdom Uzbekistan World Health Organization Regional Office for Europe UN City, Marmorvej 51, DK-2100 Copenhagen Ø, Denmark Tel.: +45 45 33 70 00 Fax: +45 45 33 70 01 Email: [email protected] Website: www.euro.who.int Self-assessment tool for the evaluation of essential public health operations in the WHO European Region Abstract Through a process of extensive and iterative consultation, the WHO Regional Office for Europe devised 10 essential public health operations (EPHOs) that define the field of modern public health for the Member States in the WHO European Region. Formally endorsed by all of the Member States in the Region,the EPHOs form a comprehensive package that all Member States should aim to provide to their populations.The public health self-assessment tool presented here provides a series of criteria with which national public health officials can evaluate the delivery of the EPHOs in their particular settings.
    [Show full text]
  • Twenty Years of the Critical Psychiatry Network Duncan B
    The British Journal of Psychiatry (2019) 214, 61–62. doi: 10.1192/bjp.2018.181 Editorial Twenty years of the Critical Psychiatry Network Duncan B. Double The Critical Psychiatry Network (CPN) was formed in 1999. This editorial attempts to define critical psychiatry and notes some key contributions from members of the CPN. The implications of Keywords critical psychiatry and some differences within the critical History of psychiatry; philosophy; aetiology. psychiatry movement are discussed. Declaration of interest Copyright and usage D.B.D is founding member of the Critical Psychiatry Network. © The Royal College of Psychiatrists 2019. biomedical model and thus does not push the necessary critique Duncan Double is a part-time Consultant Psychiatrist at Norfolk and Suffolk National far enough. By contrast, they called biomedical dogmatism the Health Service Foundation Trust and is currently doing a part-time PhD at Cambridge ‘ ’ ‘ ’ University on ‘The foundations of critical psychiatry’. He blogs on critical psychiatry at hubris position and saw it as dangerous . 5 www.criticalpsychiatry.blogspot.com. As an illustration, George Engel – in proposing his biopsycho- social model – was responding to an article by Ludwig6 entitled ‘The psychiatrist as physician’. Ludwig was concerned about anti-psychi- atric critiques. His response was to accept the vulnerability of psych- iatry to such charges and his solution was to retreat to the medical The Critical Psychiatry Network (CPN) first met in January 1999 model. As far as Ludwig was concerned, psychiatry should deal with because of concern about the potential for increasing coercion in medical illness, including neuropsychiatric and medico-psychiatric the context of reform of the Mental Health Act 1983, which eventu- disorders, rather than non-psychiatric problems, which are more ally led to the 2007 amendments.
    [Show full text]